/PRNewswire/ While several effective treatments (benzodiazepines) are currently available for the treatment of alcohol withdrawal syndrome, there is an.
Dr. Nuyten will oversee Arcus’s clinical development organization that includes nearly 200 employees and six clinical-stage programs targeting TIGIT, the adenosine axis (CD73 and dual A2a/A2b), HIF-2a and PD-1HAYWARD, Calif. (BUSINESS WIRE) Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceu.
Stock Market | Daily Herald dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.
Nektar Appoints Dimitry S A Nuyten, M D , Ph D , as Senior Vice President and Chief Medical Officer apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.